Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Lymphatic Diseases

triethylenemelamine has been researched along with Lymphatic Diseases in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Lymphatic Diseases: Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PRAETORIUS, E1
Winkelmann, RK1
Perry, HO1
Muller, SA1
Schroeter, AL1
Jordon, RE1
Rogers, RS1

Other Studies

2 other studies available for triethylenemelamine and Lymphatic Diseases

ArticleYear
[SURVIVAL TIME AND ABILITY TO WORK IN HEMOBLASTOSES TREATED BY CHEMOTHERAPY].
    Deutsches Archiv fur klinische Medizin, 1963, Dec-02, Volume: 209

    Topics: Antineoplastic Agents; Aziridines; Biomedical Research; Cyclophosphamide; Genetic Diseases, X-Linked

1963
Treatment of Sezary syndrome.
    Mayo Clinic proceedings, 1974, Volume: 49, Issue:8

    Topics: Chlorambucil; Cyclophosphamide; Dermatitis, Exfoliative; Humans; Keratoderma, Palmoplantar; Lymphati

1974